<SEC-DOCUMENT>0000320017-24-000037-index.html : 20240715 <SEC-HEADER>0000320017-24-000037.hdr.sgml : 20240715 <ACCEPTANCE-DATETIME>20240715160944 ACCESSION NUMBER: 0000320017-24-000037 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20240715 DATE AS OF CHANGE: 20240715 EFFECTIVENESS DATE: 20240715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LISATA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-280812 FILM NUMBER: 241117362 BUSINESS ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 908-229-2590 MAIL ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 FORMER COMPANY: FORMER CONFORMED NAME: CALADRIUS BIOSCIENCES, INC. DATE OF NAME CHANGE: 20170808 FORMER COMPANY: FORMER CONFORMED NAME: Caladrius Biosciences, Inc. DATE OF NAME CHANGE: 20150608 FORMER COMPANY: FORMER CONFORMED NAME: NeoStem, Inc. DATE OF NAME CHANGE: 20060906 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>s-8esppequityplanjune2024.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: s-8esppequityplanjune2024.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>2 <FILENAME>exhibit107tos-8july2024.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 2 - file: exhibit107tos-8july2024.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>ex51tos-8july2024.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: ex51tos-8july2024.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>4 <FILENAME>exhibit232tos-8july2024.htm <DESCRIPTION>EX-23.2 <TEXT> Document 4 - file: exhibit232tos-8july2024.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>mintz2.jpg <TEXT> Document 5 - file: mintz2.jpg
</DOCUMENT> </SEC-DOCUMENT>